Milestone Pharmaceuticals Inc
MIST
Get informed when a big investor buys or sells
+ FollowMarket Cap$144.42M
Close$
$0.17
86.2% downside
Current Fair Value
86.2% downsideOvervalued by 86.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $144.42 Million |
|---|---|
| Enterprise Value | $35.79 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.75 |
| Beta | 0.98 |
| Outstanding Shares | 138,691,580 |
Return
| Return on Equity | -485.27% |
|---|---|
| Return on Assets | -48.68% |
| Return on Invested Capital | -42.06% |
Valuation & Multiples
| P/E Ratio | -1.68 |
|---|---|
| PEG | -1.39 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 16.03 |
| Enterprise Value to EBIT | -0.53 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.71 |
| Debt to Equity | 3.35 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.20
Average shareholder expectationRevenue Estimate
$816,667
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.20
Average shareholder expectationRevenue Estimate
$1.14 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 2.5689▼ 473.96% |
|---|---|
| Total Calls | 84,900▲ 133.88% |
| Total Puts | 218,100▼ 17.79% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 35.73%▲ 5.39% |
|---|---|
| Total Invested | $66.40M▲ 40.63% |
| Investors Holding | 86▼ 5.00% |
ESG Score
No data